Greenwich LifeSciences at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

Greenwich LifeSciences at BIO-Europe 2026 in Cologne: 1 session (1 talk).

OrganizationBIO-Europe 2026 Attendance
greenwichlifesciences.com
Biotech
Clinical-stage company developing GP2, an immunotherapy meant to stop breast cancer from returning after surgery.
Talk
Mon Nov 9
14:00–14:15
Oncology: Greenwich LifeSciences
A final-stage trial, in the US and Europe, of a peptide immunotherapy meant to keep breast cancer from coming back.

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Greenwich LifeSciences

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction